These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4103650)

  • 1. The effect of repeated "therapeutic" courses of antilymphocytic globulin administration on skin allograft survival time in rats.
    Andeson NF; Dalton RG
    Transplantation; 1971 Jul; 12(1):54-6. PubMed ID: 4103650
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on repeated courses of antilymphocytic globulin on skin allograft survival in rats and the formation of antibody to antilymphocytic globulin.
    Dalton RG; Anderson NF; Sanders JH
    Transplantation; 1972 Jul; 14(1):65-9. PubMed ID: 4556404
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft.
    Petrányi G; Szegedi G; Fekete B
    Acta Med Acad Sci Hung; 1971; 28(2):155-8. PubMed ID: 4948114
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications in prolonged administration of antilymphocytic sera.
    Koumans RK; Billote JB; Burke JF
    Transplant Proc; 1971 Mar; 3(1):807-10. PubMed ID: 4937973
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of rapid immune elimination of anti-lymphocytic globulin in transplant patients.
    Butler WT; Rossen RD; Hersh EM; DeBakey ME; Diethrich EB; Brooks DK; Cooley DA; Nora JJ; Leachman RD; Rochelle DG; Trentin JJ; Judd KP; Beall AC; Jenkins DE; Morgen RO; Knight V
    Nature; 1969 Nov; 224(5222):856-60. PubMed ID: 4187575
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific unresponsiveness to skin allografts in mice. I. Properties of tissue extracts and their synergistic effect with antilymphocytic serum.
    Brent L; Hansen JA; Kilshaw PJ; Thomas AV
    Transplantation; 1973 Jan; 15(1):160-71. PubMed ID: 4575919
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of route of administration of antilymphocytic globulin on skin allograft survival in rats.
    Dalton RG; Touraine JL; Anderson NF; Woodruff MF
    Nature; 1970 Mar; 225(5238):1140-1. PubMed ID: 4907291
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical use of antilymphocyte globulin.
    Najarian JS; Simmons RL
    N Engl J Med; 1971 Jul; 285(3):158-66. PubMed ID: 4103453
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cell membranes with and without antilymphocyte serum on skin and heart allograft survival.
    Matolo NM; Reemtsma K; Dewitt CW
    Transplantation; 1972 Mar; 13(3):265-9. PubMed ID: 4553728
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive assay of antilymphoblast globulin in man: effect of dose, histocompatibility, and serologic response to horse gamma globulin.
    Simmons RL; Moberg AW; Gewurz H; Soll R; Tallent MB; Najarian JS
    Surgery; 1970 Jul; 68(1):62-8. PubMed ID: 4193071
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bases of antilymphocytic globulin and its therapeutic possibilities].
    Brendel W
    Arzneimittelforschung; 1970 Feb; 20(2):191-7. PubMed ID: 4191782
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of -globulin and other immunosuppressive agents on rat skin allograft survival.
    Nelken D; Glaser M
    Transplantation; 1972 Aug; 14(2):268-9. PubMed ID: 4114972
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on goat anti-CBA thymocyte globulin: the immunosuppressive activity of anti-lymphocyte globulin in mice tolerant to, or sensitized to, goat gamma-globulin.
    Fahey KJ
    Aust J Exp Biol Med Sci; 1973 Aug; 51(4):501-11. PubMed ID: 4128656
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival times of skin xenografts in mice under chronic treatment with antithymocyte serum in different dosage-timing schedules.
    Chen CM; Tsai LC; Chung CF; Han SH
    Transplantation; 1971 Sep; 12(3):157-60. PubMed ID: 4936096
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of skin allografts after oral application of ALS in rats.
    Seifert J; Ring J; Brendel W
    Nature; 1974 Jun; 249(459):776. PubMed ID: 4599458
    [No Abstract]   [Full Text] [Related]  

  • 17. The therapeutic significance of the dose response curve for antilymphocytic serum.
    Berenbaum MC; Brent L; Kilshaw PJ
    Transplantation; 1971 Jul; 12(1):18-27. PubMed ID: 4932693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolongation of allograft survival in mice by transplantation antigens incubated with normal serum. 1. Identification of the active serum fraction].
    Elie R; Liabeuf A; Lamoureux G
    Ann Immunol (Paris); 1973 Nov; 124(4):539-54. PubMed ID: 4134957
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of the immune reaction following skin allograft by antithymocyte serum therapy of the donors].
    Petrányi G; Szegedi G; Fekete B
    Orv Hetil; 1971 Aug; 112(31):1852-5. PubMed ID: 4941976
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of antilymphocyte serum on the antigen-binding cells of the blood and the survival of skin grafts].
    Dinoeva S
    Eksp Med Morfol; 1976; 15(2):89-95. PubMed ID: 776589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.